Articles From: Esperion Therapeutics Provides ETC-1002 Development Program Update; Reports Third Quarter 2014 Financial Results to STRATTEC SECURITY CORPORATION Named 2014 Supplier of the Year by Ford Rotunda


Esperion Therapeutics, Inc. (NASDAQ: ESPR), an emerging pharmaceutical company focused on developing and commercializing first-in-class, oral low-density lipoprotein cholesterol (LDL-cholesterol) lowering therapies for the treatment of hypercholesterolemia and other cardiometabolic risk markers, today provided ETC-1002 development program updates and financial results for the third quarter ended September 30, 2014.
Sign-up for Esperion Therapeutics Provides ETC-1002 Development Program Update; Reports Third Quarter 2014 Financial Results investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0982146001&sourceType=1 http://www.ccnmatthews.com/logos/20100728-dal2.jpg TORONTO, ONTARIO --
Sign-up for Dalradian Commences Trading on the AIM market of the London Stock Exchange investment picks
Maintains Top Position with 31 Expert Witnesses Recognized Compass Lexecon's Pablo Spiller Named to Most Highly Regarded Individuals List WASHINGTON , Nov.
Sign-up for FTI Consulting Professionals Recognized as Leading Expert Witnesses investment picks
SCOTTSDALE, Ariz., Nov.
Sign-up for Kona Grill Announces Expanded Credit Facility investment picks
GTx, Inc. (NASDAQ: GTXI) today announced that it has entered into a securities purchase agreement for the sale of approximately $43.4 million of its common stock and warrants to purchase common stock in a private placement.
Sign-up for GTx Announces $43.4 Million Private Placement investment picks
The Board of Directors of Source Capital, Inc. (NYSE:SOR), today declared a regular quarterly distribution of 80 cents a common share, payable December 15, 2014, to shareholders of record as of the close of business November 21, 2014.
Sign-up for Source Capital, Inc. Declares Quarterly and Special Year-End Distributions on Common Stock investment picks
Lieutenant Governor Kim Guadagno Joins with JCP&L Executives and College Presidents for Announcement MORRISTOWN, N.J. , Nov.
Sign-up for JCP&L, Brookdale Community College and Raritan Valley Community College to Offer Training Program for Future Utility Workers investment picks
SOUTHFIELD, Mich., Nov.
Sign-up for Diversified Restaurant Holdings Reports Third Quarter 2014 Results investment picks
Popular, Inc. (NASDAQ:BPOP) announced that Popular Community Bank (“PCB”), its U.S. banking subsidiary, completed the previously announced sale of its California regional operations to Banc of California, National Association a wholly owned subsidiary of Banc of California, Inc. (NYSE:BANC). As part of the transaction, PCB sold its 20 branches in the Los Angeles and Orange County areas, including approximately $1.1 billion in loans and $1.1 billion in deposits.
Sign-up for Popular Community Bank Completes the Sale of its California Regional Operations investment picks
SANTA MONICA, Calif., Oct.
Sign-up for TrueCar to Announce Third Quarter 2014 Financial Results on Thursday, November 6th investment picks
CM Finance Inc (Nasdaq:CMFN) (“CMFN” or “the Company”) today announced financial results for its fiscal first quarter ended September 30, 2014.
Sign-up for CM Finance Inc Reports Results for Its Fiscal First Quarter Ended September 30, 2014 investment picks
MAUMEE, Ohio , Nov.
Sign-up for Dana Holding Corporation Announces Tender Offer for 2019 Notes investment picks
ITASCA, Ill.
Sign-up for Arthur J. Gallagher & Co. Acquires Blue Holdings Pty Ltd investment picks
The Howard Hughes Corporation ® (NYSE:HHC) announced today that the company has secured a $600 million non-recourse construction loan from Blackstone Real Estate Debt Strategies for the development of Waiea and Anaha, the first two condominium towers at Ward Village .
Sign-up for The Howard Hughes Corporation® Closes $600 Million Construction Financing for Ward Village investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G027673-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/12/3/11G027673/Logo1-1138064045.jpg SAN JOSE, CA--(Marketwired - December 03, 2014) - At the year-end Power Matters Alliance (PMA) Member Conference in Miami today, it was announced that Energous Corporation ("Energous" or "the Company") (NASDAQ: WATT), has joined the Alliance and will chair the newly formed Uncoupled Power Working Group (UPG). UPG is chartered with the leadership and development of standardized specifications for wireless power transfer based on non-magnetic technologies such as RF, ultrasound and laser that deliver power at a distance of up to 10m (30 feet). The PMA will also manage the Certification program ensuring that products developed based upon PMA UPG specifications will be interoperable and deliver a compelling user experience to
Sign-up for Energous Corporation Joins Power Matters Alliance investment picks
Morgan Stanley announced today that its Global Stock Plan Services (GSPS) group recently launched a new online stock plan portal, StockPlan Connect, which will enable 1.5 million participants in over 150 countries to manage their equity compensation plans with ease.
Sign-up for Morgan Stanley Global Stock Plan Services Launches StockPlan Connect investment picks
SAN DIEGO, Nov.
Sign-up for Entropic to Present at Upcoming Financial Conferences investment picks
Cubic Corporation (NYSE: CUB) today reported its financial results for the fiscal year ended September 30, 2014.
Sign-up for Cubic Reports Fourth Quarter and Fiscal Year 2014 Results Including Record Quarterly Sales, Earnings, and Backlog investment picks
Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Valley Financial Corp.
Sign-up for VALLEY FINANCIAL CORP. INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Valley Financial Corp. Over the Proposed Sale of the Company to BNC Bancorp - VYFC investment picks
FORT WORTH, Texas, Nov.
Sign-up for Quicksilver Resources Reports Third-Quarter 2014 Results investment picks
Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) (“Eagle” or the “Company”) today announced positive results from a recently-conducted clinical trial of its bendamustine hydrochloride (“HCl”) product, in which the dose was delivered in a 50mL admixture in ten minutes (the “rapidly infused product”) versus a 500mL admixture in the 60-minute infusion required for Treanda ® (bendamustine HCl). In this study, Eagle’s rapidly infused product was found to be bioequivalent to Treanda, which was the primary endpoint of the study.
Sign-up for Eagle Pharmaceuticals Reports Positive Outcomes from Clinical Trial of Bendamustine HCl Product Delivered via Low-Volume, Rapidly Infused Admixture investment picks
MORRIS PLAINS, N.J., Nov.
Sign-up for Immunomedics Announces Orphan Drug Designation for Veltuzumab for the Treatment of Pemphigus investment picks
NEW YORK, Dec.
Sign-up for Annual Changes to the NASDAQ-100 Index investment picks
Covidien plc (NYSE: COV) today announced, for purposes of the Irish Takeover Rules, that the definitive joint proxy statement of Covidien plc and Medtronic, Inc., which also serves as a prospectus of Medtronic Holdings Limited and comprises Covidien’s scheme circular required under Irish law is being sent today to Covidien and Medtronic, Inc., shareholders.
Sign-up for Covidien Announces Mailing of Definitive Joint Proxy Statement/Prospectus investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Esperion Therapeutics Provides ETC-1002 Development Program Update; Reports Third Quarter 2014 Financial Results to STRATTEC SECURITY CORPORATION Named 2014 Supplier of the Year by Ford Rotunda
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent